Skip to main content
. 2019 May 9;36(Suppl 1):101–127. doi: 10.1007/s40266-019-00657-w

Fig. 3.

Fig. 3

a Risk of bias graph for studies without concomitant pharmacological OA treatment: review authors’ judgements about each risk of bias item presented as percentages across all studies included in the primary qualitative synthesis. b Risk of bias graph for studies with concomitant pharmacological OA treatment: review authors’ judgements about each risk of bias item presented as percentages across all studies included in the parallel qualitative synthesis. OA osteoarthritis